Vanguard Group Inc Maia Biotechnology, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,140,769 shares of MAIA stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,140,769
Previous 650,256
75.43%
Holding current value
$1.89 Million
Previous $994,000
106.54%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
2.26MCall Options Held
0Put Options Held
0-
Centric Wealth Management573KShares$951,8400.26% of portfolio
-
Geode Capital Management, LLC Boston, MA222KShares$368,8230.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$130,3440.0% of portfolio
-
State Street Corp Boston, MA75.6KShares$125,4130.0% of portfolio
-
Northern Trust Corp Chicago, IL39KShares$64,7930.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $18.2M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...